[go: up one dir, main page]

FI954245L - Koostumuksia ja menetelmiä immunovälitteisten tulehduksellisten häiriöiden hoitamiseksi - Google Patents

Koostumuksia ja menetelmiä immunovälitteisten tulehduksellisten häiriöiden hoitamiseksi Download PDF

Info

Publication number
FI954245L
FI954245L FI954245A FI954245A FI954245L FI 954245 L FI954245 L FI 954245L FI 954245 A FI954245 A FI 954245A FI 954245 A FI954245 A FI 954245A FI 954245 L FI954245 L FI 954245L
Authority
FI
Finland
Prior art keywords
compositions
methods
inflammatory disorders
mediated inflammatory
treating immune
Prior art date
Application number
FI954245A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI954245A0 (fi
FI954245A7 (fi
Inventor
Kerry Spear
Charles Johnson
Heinz W Gschwend
Original Assignee
Arris Pharm Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arris Pharm Corp filed Critical Arris Pharm Corp
Publication of FI954245A0 publication Critical patent/FI954245A0/fi
Publication of FI954245L publication Critical patent/FI954245L/fi
Publication of FI954245A7 publication Critical patent/FI954245A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C07K5/06095—Arg-amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI954245A 1993-03-12 1994-03-11 Koostumuksia ja menetelmiä immunovälitteisten tulehduksellisten häiriö iden hoitamiseksi FI954245A7 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3118793A 1993-03-12 1993-03-12
US3077093A 1993-03-12 1993-03-12
PCT/US1994/002706 WO1994020527A1 (en) 1993-03-12 1994-03-11 Compositions and methods for the treatment of immunomediated inflammatory disorders

Publications (3)

Publication Number Publication Date
FI954245A0 FI954245A0 (fi) 1995-09-11
FI954245L true FI954245L (fi) 1995-09-28
FI954245A7 FI954245A7 (fi) 1995-09-28

Family

ID=26706445

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954245A FI954245A7 (fi) 1993-03-12 1994-03-11 Koostumuksia ja menetelmiä immunovälitteisten tulehduksellisten häiriö iden hoitamiseksi

Country Status (11)

Country Link
EP (1) EP0688337A1 (ru)
JP (1) JPH08507768A (ru)
KR (1) KR100309616B1 (ru)
CN (2) CN1057772C (ru)
AU (1) AU683459B2 (ru)
CZ (1) CZ289930B6 (ru)
FI (1) FI954245A7 (ru)
PL (1) PL176941B1 (ru)
SK (1) SK282537B6 (ru)
UA (1) UA42719C2 (ru)
WO (1) WO1994020527A1 (ru)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0763016B1 (en) * 1994-06-01 2000-01-26 Axys Pharmaceuticals, Inc. Compositions and methods for treating mast-cell mediated conditions
NZ294392A (en) * 1994-09-23 1999-05-28 Axys Pharm Inc Asthma drugs and compounds
EP0893437A4 (en) 1996-04-10 2000-12-27 Ono Pharmaceutical Co GUANIDINO TRYPTASE INHIBITOR
EP0934293A1 (en) * 1996-07-30 1999-08-11 Arris Pharmaceutical Corporation Novel compounds and compositions for treating diseases associated with tryptase activity
WO1998024886A1 (en) * 1996-12-04 1998-06-11 Brigham And Women's Hospital, Inc. Mast cell protease that cleaves fibrinogen
WO1998033812A1 (en) * 1997-02-05 1998-08-06 Brigham And Women's Hospital, Inc. Mast cell protease peptide inhibitors
US6221914B1 (en) * 1997-11-10 2001-04-24 Array Biopharma Inc. Sulfonamide bridging compounds that inhibit tryptase activity
EP1030844A1 (en) * 1997-11-10 2000-08-30 Array Biopharma Inc. Compounds which inhibit tryptase activity
WO1999026925A1 (en) * 1997-11-26 1999-06-03 Yoshitomi Pharmaceutical Industries, Ltd. Tryptase inhibitors comprising heterocyclic amide compounds
SE9800729L (sv) * 1998-03-06 1999-09-07 Scotia Lipidteknik Ab Ny topikal formulering I
SE515982C2 (sv) * 1998-03-06 2001-11-05 Lipocore Holding Ab Användning av en olja-i-vatten emulsion som bärare för framställning av en topikal kräm eller lotion
DE19939910A1 (de) * 1999-08-23 2001-03-01 Morphochem Ag Neue Verbindungen, die Tryptase-Aktivität hemmen
GB0507577D0 (en) * 2005-04-14 2005-05-18 Novartis Ag Organic compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4201863A (en) * 1974-11-08 1980-05-06 Mitsubishi Chemical Industries, Limited N2 -Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4456595A (en) * 1982-12-06 1984-06-26 E. R. Squibb & Sons, Inc. Carboxy and substituted carboxy aroly peptides

Also Published As

Publication number Publication date
KR100309616B1 (ko) 2002-02-28
CN1057772C (zh) 2000-10-25
PL176941B1 (pl) 1999-08-31
CZ289930B6 (cs) 2002-04-17
UA42719C2 (ru) 2001-11-15
EP0688337A1 (en) 1995-12-27
CN1234229A (zh) 1999-11-10
SK112995A3 (en) 1996-10-02
PL310559A1 (en) 1995-12-27
CN1119019A (zh) 1996-03-20
AU6364794A (en) 1994-09-26
CZ232195A3 (en) 1996-07-17
JPH08507768A (ja) 1996-08-20
WO1994020527A1 (en) 1994-09-15
FI954245A0 (fi) 1995-09-11
AU683459B2 (en) 1997-11-13
FI954245A7 (fi) 1995-09-28
SK282537B6 (sk) 2002-10-08

Similar Documents

Publication Publication Date Title
KR950700732A (ko) 알러지성 및 염증성 질환의 치료에 유용한 화합물(Compounds useful for treating allergic and inflammatory diseases)
GR3036347T3 (en) Compounds useful for treating allergic and inflammatory diseases.
EP0634930A4 (en) Compounds useful for treating allergic and inflammatory diseases.
FI972781L (fi) Menetelmät ja koostumukset allergisen nuhan ja muiden sairauksien hoitamiseksi käyttäen dekarboetokyloratadieeniä
FI940932L (fi) Koostumuksia ja menetelmiä haavojen hoitamiseksi
FI971171L (fi) Koostumukset ja menetelmät syöttösolujen välittämien tulehdussairauksien hoitamiseksi
GR3036364T3 (en) Compositions and methods for treating or preventing inflammatory diseases
EP0695224A4 (en) COMPOSITIONS AND METHODS FOR TREATING WASTE
FI963692L (fi) Menetelmiä ja koostumuksia, jotka ovat käyttökelpoisia angiogeneesin inhibointiin
FI922969A7 (fi) Menetelmiä ja koostumuksia hapen poistamiseksi
FI962249A7 (fi) Substituoituja pyratsolyylibentseenisulfonamideja tulehduksen hoitoa varten
FI931738L (fi) Teknisk harts-propenymppolymerkomposition
DE69325158D1 (de) Photokromische Zusammensetzung
FI953593L (fi) G-CSF-analogikoostumuksia ja menetelmiä
FI943745L (fi) Koostumuksia ja menetelmiä proteiinin rakenteen määrityksiin
DE69325396D1 (de) Sicherungsring für entfernplattenzusammensetzung
FI932957L (fi) Glasfiberfoerstaerkt propenylpolymerkomposition
FI972433L (fi) Rantes-peptidi ja fragmentteja sekä tätä sisältäviä tulehduksen hoitoon soveltuvia koostumuksia
FI934926A7 (fi) Adsorbenttikoostumuksia ja menetelmiä niiden valmistamiseksi
FI970534L (fi) Menetelmät ja koostumukset endotoksiinin liittyvien tilojen ennaltaehkäisemiseksi ja hoitamiseksi
FI971750A7 (fi) Koostumuksia multippeliskleroosia varten ja sen hoito
DK0565078T3 (da) Hærdelig sammensætning
FI954245L (fi) Koostumuksia ja menetelmiä immunovälitteisten tulehduksellisten häiriöiden hoitamiseksi
FI965008L (fi) Koostumukset ja menetelmät kasvainten hoitamiseksi
FI961380L (fi) Koostumuksia virusten aiheuttamien kasvainten ehkäisemiseksi ja hoitamiseksi